Recent Advances in Optically Controlled PROTAC
Bioengineering · 28.11.2023 · 10 (12) · 1368
DOI: 10.3390/bioengineering10121368 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 28.11.2023. Verfasst von Muzi Ouyang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Oncogenomics, Institute of Biomedical and Health Engineering, Shenzhen International Graduate School, Tsinghua Unive…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Synthetic Biology Research, National Key R&D Program of China, Synthetic Biology Research.
Abstract (Originalsprache)
Proteolysis-targeting chimera (PROTAC) technology is a groundbreaking therapeutic approach with significant clinical potential for degrading disease-inducing proteins within targeted cells. However, challenges related to insufficient target selectivity raise concerns about PROTAC toxicity toward normal cells. To address this issue, researchers are modifying PROTACs using various approaches to enhance their target specificity. This review highlights innovative optically controlled PROTACs as anti-cancer therapies currently used in clinical practice and explores the challenges associated with their efficacy and safety. The development of optically controlled PROTACs holds the potential to significantly expand the clinical applicability of PROTAC-based technology within the realm of drug discovery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Oncogenomics, Institute of Biomedical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
- Department of Chemistry, Tsinghua University, Beijing 100084, China.
Förderung
- National Key R&D Program of China, Synthetic Biology Research
- National Key R&D Program of China, Synthetic Biology Research
Zitieren
APA
Ouyang, M., Feng, Y., Chen, H., Liu, Y., Tan, C., & Tan, Y. (2023). Recent Advances in Optically Controlled PROTAC. Bioengineering, 10(12), 1368. https://doi.org/10.3390/bioengineering10121368
Vancouver
Ouyang M, Feng Y, Chen H, Liu Y, Tan C, Tan Y. Recent Advances in Optically Controlled PROTAC. Bioengineering. 2023;10(12):1368. doi:10.3390/bioengineering10121368
BibTeX
@article{Ouyang2023,
author = {Ouyang, Muzi and Feng, Ying and Chen, Hui and Liu, Yanping and Tan, Chunyan and Tan, Ying},
title = {Recent Advances in Optically Controlled PROTAC},
journal = {Bioengineering},
year = {2023},
volume = {10},
number = {12},
pages = {1368},
doi = {10.3390/bioengineering10121368}
}
EUVIMED